Pregled bibliografske jedinice broj: 263574
Evaluacija enzimskih testova u otkrivanju klinički značajnih eritrocitnih aloprotutijela u trudnoći
Evaluacija enzimskih testova u otkrivanju klinički značajnih eritrocitnih aloprotutijela u trudnoći // Acta Medica Croatica, 53 (1999), 3; 125-128 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 263574 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Evaluacija enzimskih testova u otkrivanju klinički značajnih eritrocitnih aloprotutijela u trudnoći
(Evaluation of the enzyme test for the detection of clinically significant red blood cell antibodies during pregnancy.)
Autori
Hundrić-Hašpl, Željka ; Juraković-Lončar Nina ; Grgičević, Damir
Izvornik
Acta Medica Croatica (1330-0164) 53
(1999), 3;
125-128
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
hemolitička bolest novorođenčeta. enzimska eritrocitna aloprotutijela
(haemoliytic disease of the newborn; enzyme-only RBC antibodies)
Sažetak
In the Croatian transfusion medicine, no general agreement has yet been achieved whether red blood cell (RBC) Rhesus (Rh) antibodies detected during pregnancy only by enzyme tests can cause hemolytic disease of the newborn (HDN). Results of the detection of clinically significant RBC antibodies by low-ionic-strength additive solution antiglobulin test (LISS-IAT) and trypsin enzyme test in 22, 947 pregnant women are presented. All pregnant women in whom clinically significant RBC antibodies (RBC-CSA) were detected by LISS-IAT and/or enzyme tests were followed and observed during pregnancy. The women who had enzyme-only anti-D antibodies in their serum were followed up during subsequent pregnancies. Out of 302 positive results obtained by both techniques, irregular clinically significant enzyme-only antibodies (anti-RhD and anti-RhE specificity) were detected in 14 (4.6%) pregnant women. None of 11 RhD positive newborns whose mothers had enzyme-only anti-D antibodies, had signs of HDN after delivery. In these 11 women, anti-D antibodies were detected by LISS-IAT in the first trimenon of subsequent pregnancy. Nine infants born from subsequent pregnancies to women who had previously had enzyme-only anti-D, had clinical signs of HDN. The authors concluded that there is no need for enzyme tests in prenatal testing because enzyme tests are not reliable in the prediction of HDN.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Hrvatski zavod za transfuzijsku medicinu
Citiraj ovu publikaciju:
Časopis indeksira:
- Scopus
- MEDLINE